Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
96,015,846
Number of holders
60
Total 13F shares, excl. options
15,752,840
Shares change
-475,564
Total reported value, excl. options
$135,465,315
Value change
-$5,391,551
Put/Call ratio
4.05%
Number of buys
30
Number of sells
-33
Price
$8.6

Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q2 2021

84 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q2 2021.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15,752,840 shares of 96,015,846 outstanding shares and own 16.41% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3,041,645 shares), 5AM Venture Management, LLC (2,984,263 shares), Cormorant Asset Management, LP (1,611,623 shares), BOXER CAPITAL, LLC (1,603,361 shares), MILLENNIUM MANAGEMENT LLC (990,330 shares), Ikarian Capital, LLC (947,128 shares), VANGUARD GROUP INC (730,199 shares), Redmile Group, LLC (696,378 shares), BAKER BROS. ADVISORS LP (636,363 shares), and WELLINGTON MANAGEMENT GROUP LLP (534,700 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.